# advice_genericv3_endothelial

## USER (2026-10-17T09:22:01.062Z)

Act as a helpful assistant for a cell biologist. You cannot run code. You may use WebSearch and WebFetch. Do not open, read or write any local file.

The user writes:
"I want to count the endothelial cells and measure their area from brightfield images of a confluent endothelial monolayer (some cancer cells sit on top). Help me choose an analysis approach."

Reply to the user as you normally would.

## HARNESS NOTE (2026-10-17T09:22:01.116Z)

<system-reminder>
Your final report is delivered through SubagentHandback: when your work is complete, call SubagentHandback({message: <your full report>}). The call ends your run, so make it your last step. Only a SubagentHandback call reaches your caller as your result; plain text you write at the end is not delivered. Do not also send the report with SendMessage: your caller would get it twice.
</system-reminder>

## ASSISTANT (final report)

Recommendation: segment with a deep-learning model, Cellpose, and fine-tune it on a small set of your own annotated images. I answered from general knowledge and did not search the web, so check current Cellpose version and model names.

**Why not classical methods**
In brightfield, the borders of a confluent endothelial monolayer are low-contrast and the cells are nearly transparent. Thresholding, watershed and edge detection usually fail. Cancer cells on top add refractile halos and out-of-plane blur that make this worse.

**Suggested approach**
1. **Segment with Cellpose** (GUI or Python; the Fiji/BIOP wrapper also works). Start with the pretrained generalist ("cyto3", or the newer Cellpose-SAM model in v4) and test it on 5 to 10 representative images.
2. **Fine-tune with human-in-the-loop training.** Correct the masks in the Cellpose GUI and retrain. For a single cell type and imaging setup, 20 to 50 corrected images (a few hundred to a few thousand cells) often gives a large improvement. Include images with and without cancer cells.
3. **Handle the cancer cells in one of three ways:**
   - If they are fluorescently labeled, segment them in that channel and exclude endothelial masks that overlap them.
   - Otherwise, annotate them as a separate class or "ignore" region in your training data, or mask them manually or with a second model.
   - Either way, exclude endothelial cells that are partly covered. Their visible area underestimates the true area, and their borders are unreliable.
4. **Measure.**
   - Set the pixel size from the metadata so areas are in µm².
   - Get per-cell area with Fiji (Analyze Particles on the label image, or MorphoLibJ), `skimage.measure.regionprops`, or CellProfiler.
   - Exclude cells touching the image border from area statistics.
   - Report the median and distribution of areas, not just the mean. Cell density is count divided by field area.
5. **Validate.**
   - Hand-count and hand-outline a few held-out fields.
   - Report precision, recall and F1 for counting, and IoU for outlines.
   - Check that the model is not biased for or against cells near cancer cells.

**Alternatives**
- StarDist works well for round or convex shapes but tends to fit flat, polygonal endothelial cells less well.
- micro-SAM or Segment Anything (via napari) is good for fast interactive annotation, and can create training data for Cellpose.
- Ilastik pixel classification can separate "border" from "interior" and "cancer cell". It is quick to set up but less accurate than Cellpose in brightfield.
- Free options: QuPath (with the Cellpose extension), BiaPy, and ZeroCostDL4Mic notebooks if you don't have a local GPU.

**Biggest risk and a way to reduce it**
Everything depends on whether the cell borders are actually visible in your images. If you can change the imaging, any of these helps a lot:
- phase contrast or DIC instead of brightfield
- a junction stain such as VE-cadherin or ZO-1, or a membrane dye
- one fluorescent junction image in a subset of fields, to build ground truth you then use to train a brightfield-only model

If you can't change the imaging, expect more manual correction and a higher error rate in dense or cancer-covered regions.

To refine this I need to know the objective and pixel size, whether the images are single plane or z-stacks, whether the cancer cells are labeled, and roughly how many images you have.

## USER (2026-10-17T09:23:56.418Z)

The coordinator sent a message while you were working:
The user replies:
"Thanks. Pixel size is 0.65 µm per pixel (objective details not to hand). The images are single 2D planes, no z-stacks. The cancer cells are not labelled; only brightfield is available for the analysis. I have one field for now, and more of the same kind will follow (same microscope and settings)."

Same rules as before (you cannot run code; no local files; WebSearch/WebFetch allowed). Reply to the user as you normally would.

Address this before completing your current task.

## ASSISTANT (final report)

Thanks, that helps. The plan stays the same, with adjustments for having one field now and more later. I answered from general knowledge and did not search the web.

**What 0.65 µm/px means for you**
- Resolution is adequate. Endothelial cells are typically about 20 to 50 µm across, so roughly 30 to 80 px in diameter here. In Cellpose, set the cell diameter to about 50 px, or let it estimate it, then check by eye.
- Typical areas of roughly 500 to 2000 µm² correspond to about 1,200 to 4,700 px². Use this as a sanity check on your results, not as a filter.
- Confirm the calibration. If you don't know the objective, check the image metadata, or image a stage micrometer or hemocytometer grid once with the same setup. Your area values depend entirely on this number. Area in µm² is pixel count multiplied by 0.65², which is 0.4225.

**Working with one field**
1. **Annotate this field carefully.** Segment it with pretrained Cellpose first, then correct the masks by hand in the Cellpose GUI. If you don't have many cells, this field can still provide a few hundred.
2. **Split by region, not by cell.** Reserve about 25 to 30% of the field as a held-out test region (for example, one side or a few tiles). Train on the rest. Never report accuracy on regions the model was trained on.
3. **Treat the held-out region as a pilot test only.** The images that follow, from the same microscope and settings, will be your real test set. When they arrive, hand-correct a few of them to measure error, and retrain only if the error is too high.
4. **Keep the model, diameter and settings fixed** once you are satisfied, and apply them unchanged to every later field. That keeps the analysis consistent. Record the Cellpose version, model name and parameters for your methods section.

**Cancer cells, with brightfield only**
- You can't detect them automatically at the start. The practical option is to outline them manually as exclusion regions in Fiji or QuPath (polygon ROIs), then drop any endothelial mask that overlaps an exclusion region.
- A second step you can add later: once you have a number of fields annotated, train a small separate model (a Cellpose model, or Ilastik pixel classification) on the cancer cells. That removes most of the manual outlining for later fields. Check its output, because brightfield contrast can be inconsistent.
- Report the fraction of the field that is excluded, because heavily covered fields will be biased toward the uncovered cells.
- For cells partly hidden under a cancer cell, don't include their area in the statistics. The visible area underestimates the real area.

**Statistics**
- One field gives you descriptive numbers (count, density, area distribution) but not a comparison between conditions.
- For comparisons, use the independent experiment, well or monolayer as n, not the cell. Cells within one field are not independent. Per-cell values can be shown as distributions, with the analysis done on per-well or per-experiment medians.
- Exclude border-touching cells from the area statistics. Count density as cells divided by the analysed area, after removing excluded regions.

**Order of work**
1. Check the calibration and the pretrained model on this field.
2. Correct the masks, split the field by region, fine-tune and test.
3. Add the cancer-cell exclusion regions.
4. Run the fixed pipeline on the next fields, spot-check a few against manual counts, and export per-cell area and per-field counts to a table.

If you can share a representative image or a crop (as a description of what the borders look like), I can say more about whether brightfield alone will work. If the borders are barely visible, even a single junction-stained field would be worth acquiring, to check your segmentation against.

## USER (2026-10-17T09:24:35.030Z)

The coordinator sent a message while you were working:
The user replies:
"Here is the full field: <fig3-work>/bf3/box3/assets/brightfield_image.png (1024 x 1022 px, contrast-scaled to 8-bit for display)."

You may now use the Read tool, but only on that image file. Same rules otherwise (you cannot run code; WebSearch/WebFetch allowed). Reply to the user as you normally would.

Address this before completing your current task.

*[tool call: Read: <fig3-work>/bf3/box3/assets/brightfield_image.png]*

## ASSISTANT (final report)

I looked at the image. Brightfield alone is borderline for measuring endothelial cell area on this field, but it is workable for the cancer cells and probably for counting.

**What I see**
- **Cancer cells:** many round, bright, refractile cells with dark rims, roughly 25 to 35 px across (about 16 to 23 µm). They are scattered over the whole field, as singles and clusters of 2 to 5. They are high contrast and look easy to detect automatically.
- **Debris and artifacts:** small dark, clumpy fragments, and a few saturated bright glare blobs, for example at the right edge around y≈230 and y≈420, and at the bottom right and lower left.
- **Endothelial monolayer:** very low contrast. I can make out faint polygonal outlines and round, slightly textured nuclear regions of roughly 50 to 80 px (about 30 to 50 µm), but the borders are discontinuous and weak. They are clearest in the upper right and centre, and worst at the left and top left.
- **Illumination:** there is an uneven gradient across the field, darker toward the left.

I am judging this by eye from a downscaled, contrast-scaled view, so these sizes are approximate, not measurements.

**What this changes in my advice**
1. **Cancer-cell exclusion can be automated.** I said earlier it would probably need manual outlines. Because these cells are so distinct, segment them first (Cellpose at diameter about 30 px, or a Hough circle or LoG detector), dilate each mask by a few pixels to cover the halo, and treat those regions as excluded. Also exclude the debris and glare blobs. Check the result by overlaying it on the image.
2. **Preprocess before segmenting the endothelium.** Do flat-field or background correction (a large Gaussian or rolling-ball subtraction) to remove the illumination gradient, then a local contrast step such as CLAHE. Use the enhanced image for annotation and display, and test whether it helps the model as well.
3. **Do not expect pretrained Cellpose to work well on the endothelial cells as they are.** Expect it to under- or over-segment, and to treat the cancer cells as cells. Fine-tuning on manual outlines will be needed. Annotation will be hard, and you will not be able to outline every cell with confidence. Only outline cells where you can see a border, and mark the rest as unsure and exclude them from training and evaluation.
4. **Counting may be more reliable than area.** The faint nuclear regions may be easier to detect than the borders. Counting nuclei (one per cell) and dividing the area not covered by cancer cells by the count gives a mean area per cell, with no per-cell outlines needed. This is a mean, not a distribution, and it assumes one nucleus per cell, which you should check. If you need per-cell area, you need visible borders.
5. **The field is large, which helps.** 1024 × 1022 px at 0.65 µm/px is about 665 × 664 µm. That is enough cells to hold out a test region. Work in tiles (for example 256 × 256 px) with overlap, and split train and test by region.

**Ways to improve the contrast, if you can still change anything**
- Defocusing a few µm often raises border contrast in brightfield for flat cells like these, so a slightly out-of-focus image of the same field may be easier to segment.
- Phase contrast or DIC on the same microscope, if available.
- A junction stain or membrane dye on even one field, so you can check your brightfield outlines against it.

**Suggested next steps**
1. Check the pixel calibration and apply flat-field correction.
2. Segment and exclude the cancer cells, debris and glare, and check the result by overlay.
3. In a few tiles, outline the endothelial cells where borders are visible, and also mark nuclei. Compare the count from nuclei with the count from outlines.
4. Fine-tune Cellpose on these tiles, test on a held-out region, and report the fraction of the monolayer that could be reliably segmented along with the counts and areas.

If most of the field turns out to have no visible borders, report counts and density only, and say that per-cell area could not be measured from brightfield.
